Research · Updated 28 Oct, 02:20 am IST
Anthropic reports early progress using Claude to speed drug development
Why it matters for readers: If you're just interested, it shows AI is being tested to help make medicines faster, not only to design molecules but across the whole development process.
- Anthropic's life sciences team has collaborated with six organisations on drug development programs.1
- Partners named include BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.1
- Anthropic has begun its own drug discovery efforts alongside these partnerships.1
- The team found Claude can support many tasks across drug development, not only molecule design, and plans to improve and scale the work.1
Get a brief like this every morning
Uzha reads hundreds of sources and gives you the stories that matter for your work, with every source linked. Free.
Get started